These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 23563201)
1. The IL23R A/Gln381 allele promotes IL-23 unresponsiveness in human memory T-helper 17 cells and impairs Th17 responses in psoriasis patients. Di Meglio P; Villanova F; Napolitano L; Tosi I; Terranova Barberio M; Mak RK; Nutland S; Smith CH; Barker JNWN; Todd JA; Nestle FO J Invest Dermatol; 2013 Oct; 133(10):2381-2389. PubMed ID: 23563201 [TBL] [Abstract][Full Text] [Related]
2. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. Di Meglio P; Di Cesare A; Laggner U; Chu CC; Napolitano L; Villanova F; Tosi I; Capon F; Trembath RC; Peris K; Nestle FO PLoS One; 2011 Feb; 6(2):e17160. PubMed ID: 21364948 [TBL] [Abstract][Full Text] [Related]
3. The human IL-23 receptor rs11209026 A allele promotes the expression of a soluble IL-23R-encoding mRNA species. Yu RY; Brazaitis J; Gallagher G J Immunol; 2015 Feb; 194(3):1062-8. PubMed ID: 25552541 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Sarin R; Wu X; Abraham C Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9560-5. PubMed ID: 21606346 [TBL] [Abstract][Full Text] [Related]
5. Investigation of association of the IL-12B and IL-23R genetic variations with psoriatic risk in a South Indian Tamil cohort. Indhumathi S; Rajappa M; Chandrashekar L; Ananthanarayanan PH; Thappa DM; Negi VS Hum Immunol; 2016 Jan; 77(1):54-62. PubMed ID: 26472011 [TBL] [Abstract][Full Text] [Related]
6. Correlation between acute myeloid leukemia and IL-17A, IL-17F, and IL-23R gene polymorphism. Zhu B; Zhang J; Wang X; Chen J; Li C Int J Clin Exp Pathol; 2015; 8(5):5739-43. PubMed ID: 26191290 [TBL] [Abstract][Full Text] [Related]
7. Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status. Schmechel S; Konrad A; Diegelmann J; Glas J; Wetzke M; Paschos E; Lohse P; Göke B; Brand S Inflamm Bowel Dis; 2008 Feb; 14(2):204-12. PubMed ID: 18022867 [TBL] [Abstract][Full Text] [Related]
8. Th17 and Th22 cells in psoriatic arthritis and psoriasis. Benham H; Norris P; Goodall J; Wechalekar MD; FitzGerald O; Szentpetery A; Smith M; Thomas R; Gaston H Arthritis Res Ther; 2013 Sep; 15(5):R136. PubMed ID: 24286492 [TBL] [Abstract][Full Text] [Related]
9. The Gorman JA; Hundhausen C; Kinsman M; Arkatkar T; Allenspach EJ; Clough C; West SE; Thomas K; Eken A; Khim S; Hale M; Oukka M; Jackson SW; Cerosaletti K; Buckner JH; Rawlings DJ Front Immunol; 2019; 10():44. PubMed ID: 30740104 [TBL] [Abstract][Full Text] [Related]
11. IL23R gene polymorphism with juvenile idiopathic arthritis and its association with serum IL-17A. Emami S; Ziaee V; Rezaei A; Sadr M; Maddah M; Amirzargar AA; Rezaei N Int J Rheum Dis; 2016 Nov; 19(11):1189-1196. PubMed ID: 26016922 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression. Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555 [TBL] [Abstract][Full Text] [Related]
13. Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review. Abdollahi E; Tavasolian F; Momtazi-Borojeni AA; Samadi M; Rafatpanah H J Immunotoxicol; 2016 May; 13(3):286-300. PubMed ID: 27043356 [TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23/IL-23 receptor signaling and IL-17A production in patients with severe asthma. Newcomb DC; Cephus JY; Boswell MG; Fahrenholz JM; Langley EW; Feldman AS; Zhou W; Dulek DE; Goleniewska K; Woodward KB; Sevin CM; Hamilton RG; Kolls JK; Peebles RS J Allergy Clin Immunol; 2015 Oct; 136(4):1025-34.e11. PubMed ID: 26242299 [TBL] [Abstract][Full Text] [Related]
15. Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status. Stallhofer J; Friedrich M; Konrad-Zerna A; Wetzke M; Lohse P; Glas J; Tillack-Schreiber C; Schnitzler F; Beigel F; Brand S Inflamm Bowel Dis; 2015 Oct; 21(10):2327-40. PubMed ID: 26263469 [TBL] [Abstract][Full Text] [Related]